Your search returned 5 results.

Results
	1.	The tumor-specific de2-7 epidermal growth factor receptor (EGFR) promotes cells survival and heterodimerizes with the wild-type EGFR. [electronic resource] by Luwor, Rodney B Zhu, Hong-Jian Walker, Francesca Vitali, Angela A Perera, Rushika M Burgess, Antony W Scott, Andrew M Johns, Terrance G Producer: 20050325 In: Oncogene vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	The efficacy of epidermal growth factor receptor-specific antibodies against glioma xenografts is influenced by receptor levels, activation status, and heterodimerization. [electronic resource] by Johns, Terrance G Perera, Rushika M Vernes, Sonja C Vitali, Angela A Cao, Diana X Cavenee, Webster K Scott, Andrew M Furnari, Frank B Producer: 20070613 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Non-agonistic bivalent antibodies that promote c-MET degradation and inhibit tumor growth and others specific for tumor related c-MET. [electronic resource] by Greenall, Sameer A Gherardi, Ermanno Liu, Zhanqi Donoghue, Jacqueline F Vitali, Angela A Li, Qian Murphy, Roger Iamele, Luisa Scott, Andrew M Johns, Terrance G Producer: 20121228 In: PloS one vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Functional effects of glycosylation at Asn-579 of the epidermal growth factor receptor. [electronic resource] by Whitson, Kristin B Whitson, Stefanie R Red-Brewer, Monica L McCoy, Austin J Vitali, Angela A Walker, Francesca Johns, Terrance G Beth, Albert H Staros, James V Producer: 20060104 In: Biochemistry vol. 44 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478. [electronic resource] by Johns, Terrance G Luwor, Rodney B Murone, Carmel Walker, Francesca Weinstock, Janet Vitali, Angela A Perera, Rushika M Jungbluth, Achim A Stockert, Elisabeth Old, Lloyd J Nice, Edouard C Burgess, Antony W Scott, Andrew M Producer: 20040420 In: Proceedings of the National Academy of Sciences of the United States of America vol. 100 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)